Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. (2017)

First Author: Asaduzzaman M
Attributed to:  Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10549-017-4202-z

PubMed Identifier: 28341962

Publication URI: http://europepmc.org/abstract/MED/28341962

Type: Journal Article/Review

Volume: 163

Parent Publication: Breast cancer research and treatment

Issue: 3

ISSN: 0167-6806